0      0

040 - Hepatitis C: Diagnosis to Cure

‐ Sep 23, 2017 8:30am

Credits: None available.

Hepatitis C is increasingly an issue for CKD patients. This session addresses the campaign to test the at-risk population and outcomes to date. Treatment options, including new pharmacotherapies, cost, and outcomes, are also discussed.

Contact hours available until 9/25/19.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Conferences Committee Disclosures:

- Elizabeth St. John – Employee, Fresenius Kidney Care

- Marijo Johnson - Employee, Fresenius Medical Care

Speakers Conflict of Interest Disclosure: Lesley Miller – Grant Funding to Emory University from Gilead Services

There are no other disclosures to declare.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Learning Outcome:

Nephrology nurses will describe an increased ability to recognize, educate, and plan care for patients at risk for, or infected with, Hepatitis C.


Credits Available

You must be logged in and own this session in order to post comments.